{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:35:20Z","timestamp":1762875320604,"version":"3.37.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1124\/jpet.110.168484","type":"journal-article","created":{"date-parts":[[2010,5,15]],"date-time":"2010-05-15T01:09:31Z","timestamp":1273885771000},"page":"530-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Prevention of HIV Protease Inhibitor-Induced Dysregulation of Hepatic Lipid Metabolism by Raltegravir via Endoplasmic Reticulum Stress Signaling Pathways"],"prefix":"10.1016","volume":"334","author":[{"given":"Risheng","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily C.","family":"Gurley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine J.","family":"Studer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip B.","family":"Hylemon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M.","family":"Pandak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"2008. Raltegravir phase III study data released. AIDS Patient Care STDS 22:917.","key":"10.1124\/jpet.110.168484_bib1"},{"key":"10.1124\/jpet.110.168484_bib2","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1124\/jpet.110.168484_bib3","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1097\/00002030-200109280-00010","article-title":"HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study","volume":"15","author":"Carr","year":"2001","journal-title":"AIDS"},{"key":"10.1124\/jpet.110.168484_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12031-008-9170-7","article-title":"Endoplasmic reticulum stress-induced cell death in dopaminergic cells: effect of resveratrol","volume":"39","author":"Chinta","year":"2009","journal-title":"J Mol Neurosci"},{"key":"10.1124\/jpet.110.168484_bib5","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.clinthera.2008.10.012","article-title":"Raltegravir: the first HIV integrase inhibitor","volume":"30","author":"Cocohoba","year":"2008","journal-title":"Clin Ther"},{"key":"10.1124\/jpet.110.168484_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00126839-200708030-00003","article-title":"HIV-1 integrase inhibitors: an emerging clinical reality","volume":"8","author":"Dayam","year":"2007","journal-title":"Drugs R D"},{"key":"10.1124\/jpet.110.168484_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbrc.2009.05.148","article-title":"Lopinavir co-induces insulin resistance and ER stress in human adipocytes","volume":"386","author":"Djedaini","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.110.168484_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1310\/hct1004-233","article-title":"Cost-effectiveness of raltegravir in antiretroviral treatment-experienced HIV-1-infected patients in Switzerland","volume":"10","author":"Elbasha","year":"2009","journal-title":"HIV Clin Trials"},{"issue":"Suppl","key":"10.1124\/jpet.110.168484_bib9","doi-asserted-by":"crossref","first-page":"S412","DOI":"10.1194\/jlr.R800089-JLR200","article-title":"Nonalcoholic fatty liver disease","volume":"50","author":"Erickson","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.110.168484_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ncb1035","article-title":"The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages","volume":"5","author":"Feng","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1124\/jpet.110.168484_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipids from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.110.168484_bib12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.51.4.937","article-title":"Indinavir induces acute and reversible peripheral insulin resistance in rats","volume":"51","author":"Hruz","year":"2002","journal-title":"Diabetes"},{"key":"10.1124\/jpet.110.168484_bib13","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1517\/14656560903176446","article-title":"New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir","volume":"10","author":"Hughes","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1124\/jpet.110.168484_bib14","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/QAI.0b013e3181b17f53","article-title":"Raltegravir, etravirine, and ritonavir-boosted darunavir: a safe and successful rescue regimen for multidrug-resistant HIV-1 infection","volume":"52","author":"Imaz","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1124\/jpet.110.168484_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1086\/588794","article-title":"Atazanavir modestly increases plasma levels of raltegravir in healthy subjects","volume":"47","author":"Iwamoto","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1124\/jpet.110.168484_bib16","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1128\/AAC.01543-07","article-title":"Minimal effects of ritonavir and efavirenz on the pharmacokinetics of raltegravir","volume":"52","author":"Iwamoto","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.110.168484_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.clpt.6100281","article-title":"Safety, tolerability, and pharmacokinetics of raltegravir after single and multiple doses in healthy subjects","volume":"83","author":"Iwamoto","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.110.168484_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2007-991513","article-title":"Endoplasmic reticulum stress and liver injury","volume":"27","author":"Kaplowitz","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1124\/jpet.110.168484_bib19","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1124\/dmd.107.016196","article-title":"Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme","volume":"35","author":"Kassahun","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.168484_bib20","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2337\/diabetes.52.7.1695","article-title":"HIV protease inhibitors acutely impair glucose-stimulated insulin release","volume":"52","author":"Koster","year":"2003","journal-title":"Diabetes"},{"key":"10.1124\/jpet.110.168484_bib21","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/QAD.0b013e32826fbc54","article-title":"Effects of ritonavir and amprenavir on insulin sensitivity in healthy volunteers","volume":"21","author":"Lee","year":"2007","journal-title":"Aids"},{"key":"10.1124\/jpet.110.168484_bib22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1468-1293.2001.00071.x","article-title":"HIV-associated lipodystrophy","volume":"2","author":"Mallon","year":"2001","journal-title":"HIV Med"},{"key":"10.1124\/jpet.110.168484_bib23","first-page":"89","article-title":"HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicities","volume":"3","author":"Moyle","year":"2002","journal-title":"HIV Clin Trials"},{"key":"10.1124\/jpet.110.168484_bib24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00002030-200204120-00005","article-title":"Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations","volume":"16","author":"Murata","year":"2002","journal-title":"AIDS"},{"key":"10.1124\/jpet.110.168484_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/rmv.539","article-title":"HIV integrase inhibitors as therapeutic agents in AIDS","volume":"17","author":"Nair","year":"2007","journal-title":"Rev Med Virol"},{"key":"10.1124\/jpet.110.168484_bib26","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1124\/mol.104.010165","article-title":"Endoplasmic reticulum stress links dyslipidemia to inhibition of proteasome activity and glucose transport by HIV protease inhibitors","volume":"67","author":"Parker","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.110.168484_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jchromb.2008.03.026","article-title":"Quantification of the HIV-integrase inhibitor raltegravir (MK-0518) in human plasma by high-performance liquid chromatography with fluorescence detection","volume":"867","author":"Poirier","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1124\/jpet.110.168484_bib28","doi-asserted-by":"crossref","first-page":"37514","DOI":"10.1074\/jbc.M104557200","article-title":"HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus","volume":"276","author":"Riddle","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.110.168484_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.ATV.0000198749.28422.29","article-title":"HIV protease inhibitors and hyperlipidemia: a fatty acid connection","volume":"26","author":"Spector","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.110.168484_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMoa0708975","article-title":"Raltegravir with optimized background therapy for resistant HIV-1 infection","volume":"359","author":"Steigbigel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.110.168484_bib31","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.bbrc.2006.09.009","article-title":"ER stress contributes to ischemia-induced cardiomyocyte apoptosis","volume":"349","author":"Szegezdi","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.110.168484_bib32","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1161\/01.ATV.0000075912.83860.26","article-title":"Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux","volume":"23","author":"Wang","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.110.168484_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.gastro.2009.08.054","article-title":"HIV protease inhibitors induce endoplasmic reticulum stress and disrupt barrier integrity in intestinal epithelial cells","volume":"138","author":"Wu","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.110.168484_bib34","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/hep.22239","article-title":"Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways","volume":"47","author":"Wu","year":"2008","journal-title":"Hepatology"},{"key":"10.1124\/jpet.110.168484_bib35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2005.11.040","article-title":"Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response","volume":"124","author":"Zhang","year":"2006","journal-title":"Cell"},{"key":"10.1124\/jpet.110.168484_bib36","doi-asserted-by":"crossref","first-page":"G1071","DOI":"10.1152\/ajpgi.00182.2006","article-title":"HIV protease inhibitors activate the unfolded protein response and disrupt lipid metabolism in primary hepatocytes","volume":"291","author":"Zhou","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.110.168484_bib37","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1016\/j.atherosclerosis.2007.04.008","article-title":"HIV protease inhibitors increase TNF-alpha and IL-6 expression in macrophages: involvement of the RNA-binding protein HuR","volume":"195","author":"Zhou","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1124\/jpet.110.168484_bib38","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/mol.105.012898","article-title":"HIV protease inhibitors activate the unfolded protein response in macrophages: implication for atherosclerosis and cardiovascular disease","volume":"68","author":"Zhou","year":"2005","journal-title":"Mol Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524459272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524459272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.110.168484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:16:05Z","timestamp":1740017765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524459272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0022356524459272"],"URL":"https:\/\/doi.org\/10.1124\/jpet.110.168484","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of HIV Protease Inhibitor-Induced Dysregulation of Hepatic Lipid Metabolism by Raltegravir via Endoplasmic Reticulum Stress Signaling Pathways","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.110.168484","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}